OTX2 rs104894464: Understanding This Rare Genetic Variant
The rs104894464 variant is an extremely rare genetic change located within the OTX2 gene. It is associated with syndromic microphthalmia, a condition characterized by the underdevelopment of the eyes and potential involvement of other structures like the pituitary gland.
What each genotype means
Typical OTX2 gene structure
This is the reference genotype observed in the vast majority of the human population. It indicates that the individual does not carry the pathogenic mutation rs104894464 at this specific location in the OTX2 gene.
This is the most common genotype, found in nearly all individuals across all ancestral populations.
Pathogenic OTX2 variant
This genotype indicates the presence of one copy of the rs104894464 mutation, which is often referred to in scientific literature as R89G. Research associates this variant with syndromic microphthalmia and optic nerve hypoplasia, which are conditions affecting eye development. If you have concerns about your health or family history, please consult with a medical geneticist or physician.
This genotype is extremely rare, with the variant allele occurring at a frequency of less than 0.00001 in large population databases like gnomAD.
Pathogenic OTX2 variant
This genotype indicates that both copies of the OTX2 gene carry the rs104894464 mutation. This is a rare state associated with significant impacts on OTX2 protein function and eye development. Clinical consultation is essential for understanding the implications of this result for your health.
This genotype is exceptionally rare and is not considered a common polymorphism in any known ancestral population.
What is the rs104894464 Variant?
The rs104894464 variant is a specific change in the DNA sequence of the OTX2 gene. In genetics, a variant like this is often classified as a missense mutation, meaning it results in a change to the amino acid sequence of the protein the gene encodes. This specific variant is known to disrupt the homeodomain of the OTX2 protein. The homeodomain is a critical structural component that allows the protein to bind to DNA and regulate the activity of other genes. By interfering with this binding process, the variant can impair the protein's ability to perform its normal regulatory functions during early development. Because this variant is located in a region essential for protein function, it is categorized as pathogenic in clinical contexts, meaning it has the potential to cause significant developmental health effects.
The Role of the OTX2 Gene
The OTX2 gene, which stands for orthodenticle homeobox 2, provides instructions for making a protein that acts as a transcription factor. Transcription factors are proteins that bind to specific regions of DNA to turn genes on or off. OTX2 is particularly vital during embryonic development, where it orchestrates the formation of the forebrain, the eyes, and the pituitary gland. The pituitary gland is a small structure at the base of the brain that produces hormones essential for growth and metabolism. Because OTX2 is a master regulator, its proper function is required for the complex process of eye morphogenesis, including the development of the optic nerves that transmit visual information to the brain. When OTX2 is not functioning correctly, the downstream genes it controls may not be activated at the right time or in the right amount, leading to structural abnormalities.
Research and Clinical Associations
Research has linked mutations in the OTX2 gene to a spectrum of conditions, most notably syndromic microphthalmia type 5. Microphthalmia refers to eyes that are abnormally small, while anophthalmia refers to the absence of one or both eyes. The term 'syndromic' indicates that these eye conditions may occur alongside other systemic issues, such as pituitary hormone deficiencies or intellectual disabilities. The evidence for OTX2's role in these conditions is strong, as it is well-documented in clinical genetics literature and developmental biology studies. However, the specific impact of the rs104894464 variant is considered to have limited evidence in terms of broad population-wide studies, largely due to its extreme rarity. Most clinical data comes from case reports of individuals presenting with severe, often bilateral, ocular anomalies. Because of this, the clinical presentation can be variable, and researchers continue to study how different OTX2 variants influence the severity of these developmental outcomes.
Population Frequency and Interpretation
The rs104894464 variant is exceptionally rare, with an allele frequency reported in databases like gnomAD as less than 0.00001. This means the variant is not found in the vast majority of the human population. Because it is so rare, it is not a variant that would typically be encountered in routine consumer genetic testing or general population screening. When such a variant is identified in a clinical setting, it is usually through targeted sequencing for individuals who already exhibit symptoms of microphthalmia or related developmental disorders. It is important to understand that the presence of a rare variant does not automatically guarantee a specific health outcome, as genetic penetrance—the likelihood that a genetic change will result in a clinical condition—can be influenced by other genetic and environmental factors. Genetic findings should always be interpreted by a qualified medical geneticist or counselor who can provide context based on an individual's specific clinical history.
How common is this variant?
The rs104894464 variant is extremely rare, with an allele frequency of less than 0.00001 in the gnomAD database.
Frequently asked questions
What is OTX2-related syndromic microphthalmia?
It is a rare genetic condition where mutations in the OTX2 gene lead to underdeveloped or absent eyes, often accompanied by other issues like pituitary gland dysfunction or intellectual disability.
Is rs104894464 common in the general population?
No, this variant is extremely rare, with an allele frequency of less than 0.00001. It is not a common genetic variation found in the general public.
Can I test for this variant at home?
Most standard consumer genetic tests do not screen for this specific, rare variant. If you have concerns about eye development or genetic conditions, you should consult a medical professional or a genetic counselor.
What should I do if I have this variant?
If a clinical test has identified this variant, it is essential to discuss the results with a clinical geneticist. They can provide personalized information regarding the implications for your health or family planning.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs104894464?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in OTX2
A pathogenic point mutation causing transcription-factor loss of function resulting in severe microphthalmia, anophthalmia, and coloboma.
A well-characterized missense substitution in OTX2 causing ocular dysgenesis including coloboma, microphthalmia, and anophthalmia.